BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,177,000 | -26.4% | 199,618 | -29.0% | 0.01% | -45.5% |
| Q2 2022 | $40,984,000 | +11.1% | 281,275 | -9.6% | 0.01% | +37.5% |
| Q1 2022 | $36,888,000 | -18.3% | 311,112 | -5.1% | 0.01% | -11.1% |
| Q4 2021 | $45,170,000 | -24.5% | 327,766 | -23.9% | 0.01% | -25.0% |
| Q3 2021 | $59,813,000 | +140.7% | 430,581 | +68.2% | 0.01% | +100.0% |
| Q2 2021 | $24,850,000 | +9.9% | 255,974 | -22.6% | 0.01% | +20.0% |
| Q1 2021 | $22,619,000 | -49.4% | 330,922 | -36.5% | 0.01% | -58.3% |
| Q4 2020 | $44,684,000 | +205.3% | 521,339 | +131.6% | 0.01% | +200.0% |
| Q3 2020 | $14,636,000 | -62.4% | 225,147 | -57.7% | 0.00% | -71.4% |
| Q2 2020 | $38,903,000 | +191.0% | 532,119 | +35.5% | 0.01% | +133.3% |
| Q1 2020 | $13,368,000 | -70.2% | 392,825 | -52.4% | 0.01% | -68.4% |
| Q4 2019 | $44,880,000 | -28.5% | 824,397 | -45.2% | 0.02% | -36.7% |
| Q3 2019 | $62,796,000 | -23.4% | 1,505,165 | -19.6% | 0.03% | -18.9% |
| Q2 2019 | $81,936,000 | +104.3% | 1,871,102 | +140.1% | 0.04% | +85.0% |
| Q1 2019 | $40,113,000 | +14.1% | 779,375 | -18.0% | 0.02% | +5.3% |
| Q4 2018 | $35,162,000 | -5.5% | 950,839 | -4.1% | 0.02% | +18.8% |
| Q3 2018 | $37,225,000 | +6.1% | 991,347 | +11.7% | 0.02% | -5.9% |
| Q2 2018 | $35,085,000 | +39.5% | 887,750 | -9.1% | 0.02% | +30.8% |
| Q1 2018 | $25,150,000 | +235.1% | 976,333 | +250.9% | 0.01% | +225.0% |
| Q4 2017 | $7,506,000 | -1.4% | 278,209 | +36.6% | 0.00% | -33.3% |
| Q3 2017 | $7,614,000 | – | 203,702 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |